San Francisco, 31st October 2009: During the past few months, several leading life science organizations in the biotechnology, pharmaceutical and medical device sectors have selected the Life Sciences team of College Hill to develop and execute strategic public relations campaigns in the U.S. Among these organizations were Amarantus Therapeutics, Inc. (formerly CNS Protein Therapeutics), a Sunnyvale-based biotechnology company developing first-in-class disease-modifying treatments that address the underlying cause of cell death, and SeQual Technologies, Inc., a San Diego-based developer and manufacturer of medical oxygen systems known worldwide for their reliability, quality, and revolutionary design and economy.
Commenting on the developments, General Manager in the US, Erik Clausen, said "These latest client wins are a real boost for the whole of College Hill Life Sciences, as our San Francisco branch continues to deliver high quality communications strategies and build its' reputation in the U.S."
For further information:
Sue Charles, Managing Partner
UK: +44 (0)20 7457 2020/ +44 (0)7968 726 585
Australia: +61 (0)457 196 222
Sue CharlesManaging Partner